Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Feb-24 5:26 PM View:  | Kyverna Therapeutics, Inc. (KYTX) | 12-Feb-24 | Conversion | 2,713,870 | -- | -- | 100% 2.71M to 5.43M | |
| 14-Feb-24 5:26 PM View: | Kyverna Therapeutics, Inc. (KYTX) | 12-Feb-24 | Purchase Duplicate | 450,000 | $22.00 | $9,900,000.00 | 8% 5.43M to 5.88M | |
| 12-Jan-24 5:09 PM View: | Solid Biosciences Inc. (SLDB) | 11-Jan-24 | Grant Duplicate | 904,160 | $5.53 | $5,000,000.00 | 29% 3.13M to 4.03M | |
| 30-May-23 9:54 PM View: | Annexon, Inc. (ANNX) | 25-May-23 | Private Purchase | 300,000 | $2.13 | $639,720.00 | 6% 5.4M to 5.7M | |
| 10-Dec-21 8:33 PM View: | Xilio Therapeutics, Inc. (XLO) | 10-Dec-21 | Market Purchase | 25,000 | $9.65 | $241,202.00 | < 1% 2.78M to 2.81M | 3% |
| 10-Dec-21 8:33 PM View: | Xilio Therapeutics, Inc. (XLO) | 09-Dec-21 | Market Purchase | 4,011 | $9.84 | $39,485.10 | < 1% 2.78M to 2.78M | < 1% |
| 10-Dec-21 8:33 PM View: | Xilio Therapeutics, Inc. (XLO) | 08-Dec-21 | Market Purchase | 13,458 | $9.62 | $129,474.00 | < 1% 2.76M to 2.78M | 3% |
| 12-Aug-21 8:38 PM View: | Springworks Therapeutics, I... (SWTX) | 10-Aug-21 | Market Sale | 1,000,000 | $70.25 | $70,250,000.00 | (17%) 5.83M to 4.83M | (< 1%) |
| 21-Jul-21 4:40 PM View: | Rapid Micro Biosystems, Inc. (RPID) | 19-Jul-21 | Conversion | 8,334,560 | -- | -- | 54% 15.33M to 23.67M | |
| 21-Jul-21 4:40 PM View: | Rapid Micro Biosystems, Inc. (RPID) | 19-Jul-21 | Market Purchase | 100,000 | $20.00 | $2,000,000.00 | < 1% 23.67M to 23.77M | |
| 11-Mar-21 4:30 PM View: | Springworks Therapeutics, I... (SWTX) | 09-Mar-21 | Market Sale | 1,450,000 | $71.50 | $103,675,000.00 | (20%) 7.28M to 5.83M | 2% |
| 27-Oct-20 5:07 PM View: | Aptinyx Inc. (APTX) | 26-Oct-20 | Market Purchase | 3,333,330 | $3.00 | $10,000,000.00 | 60% 5.56M to 8.89M | 21% |
| 28-Jul-20 4:45 PM View: | Annexon, Inc. (ANNX) | 28-Jul-20 | Conversion | 2,841,630 | -- | -- | 53% 5.36M to 8.21M | |
| 28-Jul-20 4:45 PM View: | Annexon, Inc. (ANNX) | 28-Jul-20 | Purchase | 400,000 | $17.00 | $6,800,000.00 | 5% 8.21M to 8.61M | |
| 06-Feb-20 4:26 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 04-Feb-20 | Conversion | 3,685,180 | -- | -- | 57% 6.51M to 10.2M | |
| 06-Feb-20 4:26 PM View: | Arcutis Biotherapeutics, Inc. (ARQT) | 04-Feb-20 | Purchase | 294,117 | $17.00 | $4,999,990.00 | 3% 10.2M to 10.49M | |
| 21-Nov-19 4:26 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 19-Nov-19 | Market Sale | 1,750,000 | $22.03 | $38,552,500.00 | (24%) 7.33M to 5.58M | (72%) |
| 19-Sep-19 7:05 PM View: | Springworks Therapeutics, I... (SWTX) | 17-Sep-19 | Conversion | 7,131,310 | -- | -- | 100% 0 to 7.13M | |
| 19-Sep-19 7:05 PM View: | Springworks Therapeutics, I... (SWTX) | 17-Sep-19 | Purchase | 150,000 | $18.00 | $2,700,000.00 | 2% 7.13M to 7.28M | |
| 31-May-19 4:15 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 29-May-19 | Market Sale | 1,600,000 | $12.50 | $20,000,000.00 | (18%) 8.93M to 7.33M | (204%) |
| 26-Jul-18 4:27 PM View: | Replimune Group, Inc. (REPL) | 24-Jul-18 | Conversion | 2,338,970 | -- | -- | 100% 0 to 2.34M | |
| 26-Jul-18 4:27 PM View: | Replimune Group, Inc. (REPL) | 24-Jul-18 | Purchase | 500,000 | $15.00 | $7,500,000.00 | 21% 2.34M to 2.84M | |
| 19-Dec-17 8:30 PM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 19-Dec-17 | Market Sale | 150,000 | $7.43 | $1,114,670.00 | (4%) 4.13M to 3.98M | 58% |
| 19-Dec-17 4:52 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 18-Dec-17 | Grant | 190,849 | -- | -- | 100% 0 to 190.85K | |
| 19-Dec-17 4:52 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 18-Dec-17 | Option Exercise | 8,454,390 | -- | -- | 4430% 190.85K to 8.65M | |
| 19-Dec-17 4:52 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 18-Dec-17 | Market Purchase | 285,000 | $7.00 | $1,995,000.00 | 3% 8.65M to 8.93M | 443% |
| 19-Dec-17 8:30 PM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 18-Dec-17 | Market Sale | 300,000 | $7.50 | $2,251,440.00 | (7%) 4.43M to 4.13M | 58% |
| 19-Dec-17 8:30 PM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 15-Dec-17 | Market Sale | 822,547 | $8.10 | $6,658,690.00 | (16%) 5.25M to 4.43M | 62% |